GLENN PIERCE - 13 Jan 2022 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
Interim CSO, Director
Signature
/s/ Robert Hesslein, as Attorney-in-Fact for Glenn Pierce
Issuer symbol
VYGR
Transactions as of
13 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 19:05:31 UTC
Previous filing
21 Jun 2021
Next filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Award $0 +26,300 $0.000000 26,300 13 Jan 2022 Direct F1
holding VYGR Common Stock 5,000 13 Jan 2022 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VYGR Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 13 Jan 2022 Common Stock 50,000 $2.85 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock issuable under an aggregate of 26,300 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, January 13, 2022. 100% of the shares of common stock underlying the RSU award vest on the six-month anniversary of such vesting commencement date, subject to the Reporting Person's continued service as a director, officer, or otherwise.
F2 The securities are directly held by the Pierce Family Trust, dated October 13, 1993 (the "Pierce Family Trust"). The Reporting Person's immediate family members are beneficiaries of the Pierce Family Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
F3 This stock option was issued pursuant to the Plan. 1/5th of the shares of common stock underlying the option vest on each of February 12, 2022, March 12, 2022, April 12, 2022, May 12, 2022 and June 2, 2022, subject to the Reporting Person's continued service as an interim executive officer.

Remarks:

Exhibit 24.1: Limited Power of Attorney